These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37332140)

  • 1. Randomized Controlled Trial of Anti-reflux Mucosectomy Versus Radiofrequency Energy Delivery for Proton Pump Inhibitor-refractory Gastroesophageal Reflux Disease.
    Wang Y; Lv M; Lin L; Jiang L
    J Neurogastroenterol Motil; 2023 Jul; 29(3):306-313. PubMed ID: 37332140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of endoscopic anti-reflux mucosectomy and stretta radiofrequency ablation in the management of gastroesophageal reflux disease: insights from a retrospective multicenter cohort study.
    Lee AY; Kim SH; Cho JY
    Surg Endosc; 2024 Jun; ():. PubMed ID: 38866947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
    Sumi K; Inoue H; Kobayashi Y; Iwaya Y; Abad MRA; Fujiyoshi Y; Shimamura Y; Ikeda H; Onimaru M
    Dig Endosc; 2021 Mar; 33(3):347-354. PubMed ID: 32415898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of endoscopic antireflux mucosectomy
    Sui X; Gao X; Zhang L; Zhang B; Zhong C; Chen Y; Wang X; Li D; Wu W; Li L
    Ann Transl Med; 2022 Jun; 10(12):660. PubMed ID: 35845516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.
    Inoue H; Yamamoto K; Shimamura Y; Azuma D; Ushikubo K; Okada H; Kimoto Y; Nishikawa Y; Tanaka I; Tanabe M; Onimaru M; Navarro MJ
    Dig Endosc; 2024 Jun; 36(6):690-698. PubMed ID: 37899073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short and long term effect of anti-reflux mucosectomy with cap-assisted endoscopic mucosal resection for refractory gastroesophageal disease.
    Lee YS; Kim JH; Yon DK; Yoo IK
    Surg Endosc; 2024 Apr; 38(4):2180-2187. PubMed ID: 38448622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic management of gastroesophageal reflux disease: Panacea for proton pump inhibitors dependent/refractory patients.
    Kalapala R; Singla N; Reddy DN
    Dig Endosc; 2022 May; 34(4):687-699. PubMed ID: 34651353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of antireflux mucosectomy in patients with refractory gastroesophageal reflux disease.
    Sumi K; Inoue H; Ando R; Fujiyoshi MRA; Fujiyoshi Y; Tanabe M; Shimamura Y; Onimaru M
    Dig Endosc; 2024 Mar; 36(3):305-313. PubMed ID: 37332095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study (with video).
    Patil G; Dalal A; Maydeo A
    Dig Endosc; 2020 Jul; 32(5):745-752. PubMed ID: 31834663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms, the GerdQ score and patients' characteristics do not predict gastroesophageal reflux disease in patients with proton-pump-inhibitor-refractory reflux symptoms-results from a large prospective database.
    Labenz J; Menzel M; Hirsch O; Müller M; Labenz C; Adarkwah CC
    PeerJ; 2023; 11():e14802. PubMed ID: 36846452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical feasibility of antireflux mucosectomy and antireflux mucosal ablation in the management of gastroesophageal reflux disease: Retrospective cohort study.
    Lee AY; Kim SH; Cho JY
    Dig Endosc; 2024 Jun; ():. PubMed ID: 39031614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open access capture of patients with gastroesophageal reflux disease using an online patient-reported outcomes instrument.
    Tielemans MM; Jansen JB; van Oijen MG
    Interact J Med Res; 2012 Sep; 1(2):e7. PubMed ID: 23611985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the presence of an esophageal motor disorder influence the response to anti-reflux mucosectomy (ARMS) for refractory GERD?
    Onana Ndong P; Gonzalez JM; Beyrne A; Barthet M; Vitton V
    Scand J Gastroenterol; 2024 Jun; 59(6):639-646. PubMed ID: 38497142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-reflux mucosectomy for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.
    Garg R; Mohammed A; Singh A; Schleicher M; Thota PN; Rustagi T; Sanaka MR
    Endosc Int Open; 2022 Jun; 10(6):E854-E864. PubMed ID: 35692929
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study.
    Yoo IK; Ko WJ; Kim HS; Kim HK; Kim JH; Kim WH; Hong SP; Yeniova AÖ; Cho JY
    Surg Endosc; 2020 Mar; 34(3):1124-1131. PubMed ID: 31139995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Yu CJ; Chou JW; Feng CL; Wang KT; Lai HC; Hsieh CL
    Phytomedicine; 2019 Mar; 56():118-125. PubMed ID: 30668332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-reflux mucosectomy (ARMS) for refractory gastroesophageal reflux disease.
    Zhu X; Shen J
    Eur J Med Res; 2024 Mar; 29(1):185. PubMed ID: 38500203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R; Gyawali CP; Pandolfino JE;
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Study of the Safety and Efficacy of Endoscopic Radiofrequency Therapy Under Direct Vision in 59 Patients with Gastroesophageal Reflux Disease from 2 Centers in Beijing, China Using the Gastroesophageal Reflux Disease Questionnaire.
    Lu D; Bi CS; Wei X; Guo BN; Gao YX; Chen J; Qian J; Guo ZH; Wang YB; Li L; Zhang C; Hao JY; Gao Y
    Med Sci Monit; 2022 Feb; 28():e933848. PubMed ID: 35194010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of the Gastroesophageal Reflux Disease Questionnaire (GerdQ) in predicting the proton pump inhibitor response in coronary artery disease patients with gastroesophageal reflux-related chest pain.
    He S; Liu Y; Chen Y; Tang Y; Xu J; Tang C
    Dis Esophagus; 2016 May; 29(4):367-76. PubMed ID: 25721424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.